Apollo Endosurgery Stock Soars on Buyout Buzz

APEN hit a one-year high after the news broke

Deputy Editor
Nov 29, 2022 at 10:50 AM
facebook twitter linkedin

Apollo Endosurgery Inc (NASDAQ:APEN) stock is soaring, up 63.4% at $9.80 at last glance, after news that Boston Scientific Corp (BSX) will acquire the medical equipment name for $417 million. The deal, which is expected to close in the first half of 2023, is valued at roughly $615 million including debt, and will expand BSX's portfolio of gastric devices. 

Today's pop has APEN trading at fresh one-year highs, as well as gapping well above its 320-day moving average. A short-term bounce was already in the cards, too, as the stock's 14-day relative strength index (RSI) of 29.5 stands in "oversold" territory. Year-to-date, the equity is now up 17.1%. 

APEN's options volume is typically nonexistent, making the 1,935 calls exchanged so far much more notable. The December 10 call accounts for most of this activity, with positions being opened there. 

Analysts are firmly bullish on Apollo Endosurgery stock. All three firms in coverage carry a "strong buy" rating, while the 12-month consensus price target of $12.60 is a hefty 27.5% premium to current levels. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners